Published in J Endocrinol Invest on December 01, 2006
Somatostatin agonists for treatment of acromegaly. Mol Cell Endocrinol (2007) 0.92
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly. Pituitary (2016) 0.83
Outcome of endoscopic transsphenoidal surgery in combination with somatostatin analogues in patients with growth hormone producing pituitary adenoma. J Korean Neurosurg Soc (2014) 0.79
Results of gamma knife radiosurgery in acromegaly. Int J Endocrinol (2012) 0.77
The manifesto A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) study group one year later: what to keep and what to amend? J Endocrinol Invest (2007) 0.76
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med (1998) 3.98
A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab (2010) 2.33
Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab (2001) 2.13
Impairment of GH secretion in adults with primary empty sella. J Endocrinol Invest (2002) 2.09
Role of conventional ultrasonography and color flow-doppler sonography in predicting malignancy in 'cold' thyroid nodules. Eur J Endocrinol (1998) 2.09
Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med (1984) 2.01
Thyroid function differently affects serum cystatin C and creatinine concentrations. J Endocrinol Invest (2005) 1.86
Growth hormone secretagogue binding sites in peripheral human tissues. J Clin Endocrinol Metab (2000) 1.83
Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest (2002) 1.65
Evaluation of the horseradish peroxidase-scopoletin method for the measurement of hydrogen peroxide formation in biological systems. Anal Biochem (1977) 1.61
Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin Endocrinol (Oxf) (2000) 1.60
Thyroid volume measurement by ultrasound in children as a tool for the assessment of mild iodine deficiency. J Clin Endocrinol Metab (1994) 1.57
The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab (1999) 1.56
Consensus statement: medical management of acromegaly. Eur J Endocrinol (2005) 1.54
Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine (2013) 1.48
Activity of GH/IGF-I axis in patients with dilated cardiomyopathy. Clin Endocrinol (Oxf) (1999) 1.48
Circulating ghrelin levels in the newborn are positively associated with gestational age. Clin Endocrinol (Oxf) (2004) 1.44
Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest (2000) 1.44
Hypopituitaric patients with corticotropin insufficiency show marked impairment of the cortisol response to ACTH (1-24) independently of the duration of the disease. J Endocrinol Invest (2003) 1.43
Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans. J Clin Endocrinol Metab (2004) 1.40
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? J Endocrinol Invest (2002) 1.40
Study of serum 3,5,3'-triiodothyronine sulfate concentration in patients with systemic non-thyroidal illness. Eur J Endocrinol (1996) 1.38
ACROSTUDY: the Italian experience. Endocrine (2014) 1.38
Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab (2001) 1.37
Arachnoid cyst with intracystic haemorrhage and subdural haematoma: case report and literature review. Neurol Sci (2006) 1.37
Relationship between breast cancer and thyroid disease: relevance of autoimmune thyroid disorders in breast malignancy. J Clin Endocrinol Metab (1996) 1.35
Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab (2001) 1.32
Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest (1986) 1.31
Increased biliary glutathione disulfide release in chronically ethanol-treated rats. FEBS Lett (1979) 1.30
Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab (1996) 1.29
Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab (2004) 1.28
Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med (1998) 1.28
Size reduction of macroprolactinomas by bromocriptine or lisuride treatment. J Clin Endocrinol Metab (1981) 1.27
Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol (2000) 1.24
Primary empty sella: Why and when to investigate hypothalamic-pituitary function. J Endocrinol Invest (2010) 1.21
Purification of recombinant antigenic epitopes of the human 68-kDa (U1) ribonucleoprotein antigen using the expression system pH6EX3 followed by metal chelating affinity chromatography. Protein Expr Purif (1992) 1.19
Thyroid abnormalities during lithium treatment. Acta Psychiatr Scand (1991) 1.18
The extended endoscopic endonasal approach to the clivus and cranio-vertebral junction: anatomical study. Childs Nerv Syst (2007) 1.16
Insulin-like growth factor binding protein-3 induces angiogenesis through IGF-I- and SphK1-dependent mechanisms. J Thromb Haemost (2007) 1.16
Sleep abnormalities in type 2 diabetes may be associated with glycemic control. Acta Diabetol (2008) 1.16
Low serum thyroglobulin as a clue to the diagnosis of thyrotoxicosis factitia. N Engl J Med (1982) 1.14
Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res (1987) 1.13
Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int J Obes Relat Metab Disord (1999) 1.11
Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab (1994) 1.11
High prevalence of subacute thyroiditis during summer season in Italy. J Endocrinol Invest (1987) 1.11
CHLORAMPHENICOL (CHLOROMYCETIN), AN ANTIBIOTIC. PHARMACOLOGICAL AND PATHOLOGICAL STUDIES IN ANIMALS. J Clin Invest (1949) 1.10
Current management practices for acromegaly: an international survey. Pituitary (2011) 1.10
Is thyroxine during lithium therapy necessary? J Endocrinol Invest (1999) 1.10
Treatment of trigeminal neuralgia by ophthalmic anesthetic. J Neurosurg (1992) 1.09
Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism. J Clin Endocrinol Metab (1999) 1.09
Minimally invasive video-assisted surgery of the thyroid: a preliminary report. Langenbecks Arch Surg (2000) 1.08
More on smoking habits and Graves' ophthalmopathy. J Endocrinol Invest (1989) 1.08
A special case of bilateral ovarian metastases in a woman with papillary carcinoma of the thyroid. Exp Clin Endocrinol Diabetes (2007) 1.08
Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab (2001) 1.07
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocrinol Metab (2000) 1.07
Cloning and expression of antigenic epitopes of the human 68-kDa (U1) ribonucleoprotein antigen in Escherichia coli. Biotechniques (1991) 1.05
Free-living amoebae, a training field for macrophage resistance of mycobacteria. Clin Microbiol Infect (2009) 1.05
C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. Eur J Endocrinol (2012) 1.04
Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. Diabetes Obes Metab (2011) 1.04
Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid (1997) 1.03
Effects of "jet lag" on hormonal patterns. I. Procedures, variations in total plasma proteins, and disruption of adrenocorticotropin-cortisol periodicity. J Clin Endocrinol Metab (1981) 1.03
Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia. Int J Clin Pract (2008) 1.03
Circulating cytokine balance and activation markers of leucocytes in Q fever. Clin Exp Immunol (1999) 1.03
Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. J Endocrinol Invest (1995) 1.02
Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab (1996) 1.02
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy. J Clin Endocrinol Metab (2001) 1.01
Simultaneous presentation of meningiomas with other intracranial tumours. Br J Neurosurg (2005) 1.00
Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest (2012) 1.00
Measurement of serum free thyroid hormone concentrations: an essential tool for the diagnosis of thyroid dysfunction. Horm Res (1996) 1.00
Effects of antithyroid therapy on the long-acting thyroid stimulator and the antithyroglobulin antibodies. J Clin Endocrinol Metab (1969) 1.00
Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Thyroid (1997) 0.99
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population. J Endocrinol Invest (2008) 0.99
Benign intrasellar cysts. Surg Neurol (1981) 0.98
Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest (1993) 0.98
Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children. Clin Endocrinol (Oxf) (2006) 0.98
Strong antioxidant activity of ellagic acid in mammalian cells in vitro revealed by the comet assay. Anticancer Res (2002) 0.97
Long-term follow-up of 'cured' prolactinoma patients after successful adenomectomy. Clin Endocrinol (Oxf) (1990) 0.97
Stimulatory effect of adrenocorticotropin on cortisol, aldosterone, and dehydroepiandrosterone secretion in normal humans: dose-response study. J Clin Endocrinol Metab (2000) 0.97
Alterations in ventricular size and intracranial pressure caused by sagittal sinus pathology in man. J Neurosurg (1980) 0.97
Ontogenetic patterns of thyrotropin-releasing hormone-like material in rat hypothalamus, pancreas, and retina: selective effect of light deprivation. Proc Natl Acad Sci U S A (1980) 0.97
Endoscopic fenestration of symptomatic septum pellucidum cysts: three case reports with discussion on the approaches and technique. Minim Invasive Neurosurg (2002) 0.96
Molecular genetic studies of sporadic pituitary tumors. J Clin Endocrinol Metab (1994) 0.96
Tolosa-Hunt syndrome extending in the cerebello-pontine angle. Cephalalgia (2005) 0.96
Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test. J Clin Endocrinol Metab (2000) 0.96
Production of recombinant rat interleukin-6 in Escherichia coli using a novel highly efficient expression vector pGEX-3T. Biotechniques (1992) 0.96
Iodide excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. Endocrinology (2000) 0.96
Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol (2012) 0.96
The endoscopic endonasal trans-sphenoidal approach to the sellar and suprasellar area. Anatomic study. J Neurosurg Sci (2007) 0.96
Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Eur J Endocrinol (1999) 0.96
Malignant astrocytoma associated with arteriovenous malformation. Case report. Acta Neurochir (Wien) (1979) 0.95
Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab (1998) 0.95
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly. J Endocrinol Invest (2009) 0.95
Ghrelin elicits a marked stimulatory effect on GH secretion in freely-moving rats. Eur J Endocrinol (2000) 0.94
Effects of short-term administration of low-dose rhGH on IGF-I levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur J Endocrinol (2001) 0.94
Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg (1995) 0.94
Concurrent spontaneous CSF otorrhea and rhinorrhea. Eur Neurol (1982) 0.94
Arginine-induced hypophosphatemia and hyperkaliemia in man. Diabete Metab (1979) 0.94
Cost-of-illness study in acromegalic patients in Italy. J Endocrinol Invest (2004) 0.94